NHP2 and nonpapillary renal cell carcinoma: This integrative strategy not only provides robust genetic evidence supporting a causal role for TL in ccRCC susceptibility but also elucidates novel mechanisms through telomerase-associated genes (such as NOP10 and NHP2).